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Overall and abdominal obesity are well-established risk factors for cardiometabolic disease.
However, associations of overall and abdominal adiposity with electrocardiographic (ECG)
markers of subclinical cardiovascular disease (CVD) have not yet been fully elucidated. There-
fore, we investigated these associations in a population without preexisting CVD.We performed
cross-sectional analyses in the Netherlands Epidemiology of Obesity Study. Body mass index
(BMI), total body fat, and waist circumference were assessed in all participants, and ab-
dominal subcutaneous adipose tissue and visceral adipose tissue (by magnetic resonance
imaging) were assessed in a random subgroup. ECG parameters were determined using
12-lead electrocardiograms. We performed linear regression analyses, adjusting for poten-
tial confounding factors and, when investigating abdominal adiposity, additionally for total
body fat. After exclusion of participants with preexisting CVD (n = 654), 5,939 individuals
(42% men) were analyzed, with a mean (SD) age of 55 (6) years and BMI of 26.3 (4.4) kg/m2.
Measures of both overall and abdominal adiposity were associated with ECG parameters
but none of these measures was more strongly associated than the others. For example, heart
rate (beats/min) increased per SD higher BMI (2.2; 95% confidence interval 1.9,2.5), total
body fat (2.9; 2.4,3.4), subcutaneous adipose tissue (2.3;1.7,2.9), waist circumference (2.1;
1.4,2.8), and visceral adipose tissue (1.7; 0.8,2.5). In subgroup analyses based on gender and
cardiovascular risk factors, no consistent interactions were observed. In conclusion, in a
middle-aged population without preexisting CVD, measures of both overall and abdominal
adiposity were associated with ECG parameters. Future studies should evaluate the added
value of adiposity measures in electrocardiography-based diagnoses and the prognostic value
of adding adiposity measures to risk prediction tools. © 2017 The Author(s). Published
by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). (Am J Cardiol 2018;121:570–578)
Several studies have shown that high abdominal fat,
especially excess visceral adipose tissue (VAT), plays an
important role in the increased cardiometabolic risk associ-
ated with excess fat mass, on top of the important role that
overall adiposity plays.1–3 Both overall and abdominal adi-
posity have been associated with cardiovascular end points,
and more rarely with subclinical cardiovascular disease
(CVD).4–8 Excess fat mass is often assessed by body mass
index (BMI); however, this might not be the best measure
because it does not distinguish fat mass from fat-free mass.
Total body fat and subcutaneous adipose tissue are more
accurate measures of overall adiposity, and waist circumfer-
ence and VAT are more accurate measures of abdominal
adiposity. Reports on associations between both measures
of overall and abdominal adiposity and commonly used
electrocardiographic (ECG) parameters indicative of sub-
clinical CVD (in a population without preexisting CVD)
are scarce. Electrocardiography is widely used in clinical
practice for diagnostics and also has significant prognostic
value for CVD and mortality.9 We therefore focused on
subtle changes in ECG parameters, which do not have
immediate obvious importance, but that have previously
been associated with a broad range of future cardiovascular
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abnormalities or mortality.10–17 We aimed to investigate
associations between measures of overall and abdominal
adiposity and ECG parameters in a population without
preexisting CVD.
Methods
The Netherlands Epidemiology of Obesity (NEO) Study
is a prospective, population-based cohort study with 6,671
individuals, included between 2008 and 2012. Men and
women aged between 45 and 65 years, living in the area of
greater Leiden (in the Netherlands), and with a BMI ≥ 27 kg/m2
were eligible to participate. In addition, all inhabitants aged
between 45 and 65 years from 1 municipality (Leiderdorp)
were invited to join irrespective of their BMI, allowing a
reference distribution of BMI. Participants completed a ques-
tionnaire on demographic and clinical information before
the visit to the NEO study center. Participants were invited
to a baseline visit at the NEO study center after an over-
night fast. Participants with preexisting CVD were excluded
from the present analyses because we were interested in
subclinical CVD. Preexisting CVD was defined as either
self-reported myocardial infarction, angina, congestive heart
failure, stroke or peripheral vascular disease, or as presence
of Minnesota codes for atrial fibrillation, left bundle branch
block, right bundle branch block or Wolff-Parkinson-White
syndrome, or as presence of an artificial pacemaker.18 Addi-
tionally, individuals with missing electrocardiograms were
excluded. More information on the study design and popu-
lation has been published elsewhere.19 The Medical Ethics
Committee of the Leiden University Medical Center ap-
proved the design of the study. All participants gave their
written informed consent.
Ethnicity was self-reported in 8 categories on the question-
naire and then grouped into white and other. Education level was
grouped as low (none, primary school, or lower vocational edu-
cation) and high education (intermediate secondary education,
middle-level vocational education, higher secondary educa-
tion, higher professional education, university, or other). Tobacco
smoking was categorized into current, former, or never smokers.
Alcohol consumption was reported on a food frequency ques-
tionnaire and recalculated into gram/day.20 Participants reported
their physical activity using the Short Questionnaire to Assess
Health-Enhancing Physical Activity, and physical activity was
expressed in hours per week of metabolic equivalents.21 Partici-
pants were asked to bring all medications they were currently
using to the study visit. Height and weight were measured without
shoes and 1 kg was subtracted from the weight to correct for the
weight of clothing. BMI was calculated by dividing the weight
in kilograms by the height in meters squared. Waist circumfer-
ence was measured with a horizontally placed flexible tape in
the middle of the distance between the lowest rib and the iliac
crest. With a bioimpedance device (TBF-310, Tanita Interna-
tional Division,Yiewsley, United Kingdom), total body fat was
estimated.Abdominal subcutaneous adipose tissue and VAT were
assessed by magnetic resonance imaging (1.5 T magnetic reso-
nance imaging, Philips Medical Systems, Best, the Netherlands)
using a turbo spin echo imaging protocol in a random group of
2,580 participants without contraindications for magnetic reso-
nance imaging (most notably metallic devices, claustrophobia,
or a body circumference of more than 1.70 m). Three transverse
images with a slice thickness of 10 mm were obtained at the level
of the fifth lumbar vertebra during a breath-hold. The fat depots
were converted from the number of pixels to centimeters squared.
In the analyses, the average of the 3 slices was used. Brachial
blood pressure was measured in a seated position on the right
arm using a validated automatic oscillometric device (OMRON,
Model M10-IT, Omron Health Care Inc, Lake Forest, Illinois).
Blood pressure was measured 3 times with 5-minute rest between
consecutive measurements. The mean systolic and diastolic blood
pressure were calculated. Blood was sampled after an over-
night fast of 10 hours. Fasting glucose, triglyceride, high-
density lipoprotein, and low-density lipoprotein concentrations
were measured with the enzymatic colorimetric method (Roche
Modular Analytics P800, Roche Diagnostics Mannheim,
Germany).A12-lead electrocardiogram at rest was obtained using
a Mortara Eli-350 electrocardiograph (Mortara Instrument Inc.,
Milwaukee, Wisconsin) after a period of rest of at least 10
minutes. ECGs were stored in a MegaCare electrocardiogram
management system (Dräger, Zoetermeer, the Netherlands).
Values for heart rate, P-wave duration, QRS complex duration,
PR interval, corrected QT interval (corrected according to the
Bazett formula), P-wave axis, T-wave axis, and QRS axis were
recalculated using the GRI interpretation program, which is part
of the management system, to assess subtle changes in ECG pa-
rameters, which could indicate subclinical CVD in a population
without known overt CVDs.22
We defined various subgroups to perform stratified analy-
ses in, namely, men or women, high or normal blood pressure
levels, serum triglyceride, fasting plasma glucose, serum high-
density lipoprotein cholesterol, and serum low-density
lipoprotein cholesterol concentrations. Cut-off points were
used that were proposed by the National Cholesterol Edu-
cation Program Adult Treatment Panel III to define the
metabolic syndrome, with minor modifications as stated in
the American Heart Association and the National Heart, Lung,
and Blood Institute statement and additionally also cut-off
points for low-density lipoprotein cholesterol.23 High blood
pressure was defined as blood pressure ≥ 130 sys-
tolic ≥ 85 mm Hg diastolic or on antihypertensive drug
treatment in a patient with a history of hypertension; high
serum triglyceride concentrations were defined as serum tri-
glycerides ≥ 150 mg/dl or 1.7 mmol/L or use of prescription
drugs to reduce serum triglyceride concentrations; low serum
high-density lipoprotein cholesterol was defined as serum
high-density lipoprotein cholesterol < 40 mg/dl or 1.03 mmol/L
for men and <50 mg/dl or 1.3 mmol/L for women or use of
prescription drugs to elevate serum high-density lipoprotein
cholesterol; high fasting plasma glucose was defined as fasting
plasma glucose ≥ 100 mg/dl or 5.56 mmol/L or use of pre-
scription drugs to lower plasma glucose concentrations; and
high serum low-density lipoprotein cholesterol is defined as
serum low-density lipoprotein cholesterol > 160 mg/dl or
4.1 mmol/L or use of prescription drugs to reduce serum
low-density lipoprotein cholesterol concentrations.
In the NEO study, there is an oversampling of individu-
als with a BMI of 27 kg/m2 or higher. Adjustments for the
oversampling of individuals with BMI ≥ 27 kg/m2 were made
to correctly represent baseline associations in the general popu-
lation. This was done by weighing individuals toward the BMI
distribution of participants from the Leiderdorp municipal-
ity, whose BMI distribution was similar to the BMI distribution
571Preventive Cardiology/Overall/Abdominal Adiposity and Electrocardiographic Parameters
of the general Dutch population.24 All results are based on
weighted analyses. Consequently, the results apply to a
population-based study without oversampling of individu-
als with a BMI ≥ 27 kg/m2. The data of the baseline
characteristics were presented as mean (SD), median
(interquartile range), or as percentage. We calculated Z-scores
and standardized the adiposity measures to a mean of 0 and
a standard deviation of 1. The associations between the mea-
sures of overall adiposity (BMI, total body fat, and
subcutaneous adipose tissue) and the measures of abdomi-
nal adiposity (waist circumference and VAT) with the ECG
parameters heart rate (beats/min), P-wave duration (milli-
seconds), QRS complex duration (milliseconds), PR interval
(milliseconds), corrected QT interval (milliseconds), P-wave
axis (°), T-wave axis (°), and QRS axis (°) were investi-
gated using linear regression analyses and expressed as
difference in ECG parameter with 95% confidence interval
(CI). In crude models, the associations of waist circumfer-
ence and VAT were adjusted for total body fat. Adjusted models
were additionally adjusted for age, gender, ethnicity, smoking,
alcohol intake, education level, physical activity, presence of
chronic obstructive pulmonary disease, and use of several drugs
that could influence the ECG parameters, namely, use of
digoxin, class I/III blocking medication, β blockers, calcium
channel blockers, and QT-prolonging drugs.
Analyses were repeated in the previously described sub-
groups. We tested for interaction between adiposity measures
and subgroups by including product terms in the models. Data
were analyzed using STATA version 14 (Statacorp, College
Station, Texas, USA).
Results
In the NEO study, 6,671 participants were included. For
the present analysis, we consecutively excluded partici-
pants with a self-reported history of CVD (n = 464), right
bundle branch block (n = 95), left bundle branch block (n = 41),
atrial fibrillation (n = 42), artificial pacemaker (n = 8),
Wolff-Parkinson-White syndrome (n = 4), or missing elec-
trocardiogram (n = 78), leaving 5,939 participants for the main
analysis. Measurements of visceral and subcutaneous adipose
tissue were available in 2,331 participants. The baseline char-
acteristics of the study population are presented in Table 1.
The mean (SD) age was 55 (6) years and 42% were men. Al-
though women had more total body fat and more subcutaneous
adipose tissue, men had higher BMI and more VAT.
Figure 1 is a graphical representation of the associations
of the standardized measures of overall and abdominal adi-
posity with all ECG parameters. The crude model shows
associations of all adiposity measures with heart rate, P-wave
axis, T-wave axis, and QRS axis, and less consistent asso-
ciations for P-wave duration, QRS duration, PR interval, and
corrected QT interval. The adjusted model showed that both
measures of abdominal and overall adiposity were associ-
ated with higher heart rate. For example, 1 SD higher total
body fat was associated with 2.9 beats/min higher heart rate
Table 1
Characteristics of 5,939 participants aged 45 to 65 year from the Netherlands Epidemiology of Obesity Study
Total population Men (42%) Women (58%)
Age (years) 55 ± 6 56 ± 6 55 ± 6
Ethnicity, white 95% 95% 95%
Education level, low* 19% 18% 20%
Smoker
Never 39 36 42
Former 45 46 44
Current 16 18 14
Alcohol intake (grams/day) 9.8 (2.8 , 21.3) 16.4 (6.0 , 28.1) 7.7 (1.6 , 14.8)
Physical activity (MET-hour/week) 29.8 (15.3 , 49.3) 30.7 (15.0 , 50.0) 29.0 (15.8 , 48.5)
Fasting glucose (mmol/l; mg/dl) 5.4 ± 1.0;98.1 ± 17.1 5.7 ± 1.1; 101.8 ± 20.0 5.3 ± 0.8;95.4 ± 14.0
Use of glucose lowering therapy 2% 3% 2%
Systolic blood pressure (mmHg) 130.0 ± 17.1 134.4 ± 15.5 126.8 ± 17.5
Diastolic blood pressure (mmHg) 83.2 ± 10.3 85.0 ± 10.1 81.9 ± 10.3
Use of antihypertensive therapy 21% 20% 21%
Triglycerides (mmol/l; mg/dl) 1.0 (0.7 , 1.5);
88.6 (63.8 , 129.3)
1.2 (0.8 , 1.7);
102.7 (72.6 , 148.8)
0.9 (0.7 , 1.3);
81.5 (60.2 , 115.1)
HDL-cholesterol (mmol/l; mg/dl) 1.6 ± 0.5; 61.3 ± 17.8 1.4 ± 0.4; 52.2 ± 14.1 1.8 ± 0.4; 67.9 ± 17.0
LDL-cholesterol (mmol/l; mg/dl) 3.6 ± 1.0; 138.2 ± 37.2 3.6 ± 1.0; 138.8 ± 38.1 3.6 ± 0.9; 137.8 ± 36.5
Use of lipid lowering therapy 8% 11% 6%
Waist circumference (cm) 91.8 ± 13.2 98.0 ± 11.3 87.2 ± 12.5
BMI (kg/m2) 26.3 ± 4.4 26.8 ± 3.8 25.9 ± 4.7
Total body fat (%) 31.8 ± 8.7 24.8 ± 6.0 36.9 ± 6.4
VAT (cm2) (n = 2331) 88.3 ± 55.2 113.5 ± 60.4 66.4 ± 40.3
SAT (cm2) (n = 2331) 234.6 ± 96.5 207.1 ± 84.2 258.4 ± 98.3
BMI = body mass index; HDL = high-density lipoprotein; LDL = low-density lipoprotein; MET = metabolic equivalent of task; SAT = subcutaneous adipose
tissue; VAT = visceral adipose tissue.
Results were based on analyses weighted toward the BMI distribution of the general population (n = 5939).
Results are presented as mean ± SD, median (IQR) or percentage.
* Lower education: none, primary school, lower vocational education.
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(95% CI 2.4, 3.4) and 1 SD higher VAT with 1.7 beats/min
(0.8, 2.5) higher heart rate. All measures of adiposity were
associated with P-wave duration except for VAT adjusted for
total body fat (β −0.8 millisecond; 95% CI −2.1, 0.4). BMI,
total body fat, and waist circumference were positively
associated with QRS duration, whereas no associations were
found for subcutaneous adipose tissue (0.4 millisecond; −0.2,
1.0) and VAT (−0.5 millisecond; −1.3, 0.4). BMI (1.3
Figure 1. Associations of standardized obesity measures with electrocardiographic (ECG) parameters in 5,939 participants aged 45 to 65 years from the Neth-
erlands Epidemiology of Obesity Study (2,331 with VAT and SAT). Results were based on linear regression analyses weighed toward the BMI distribution of
the general population (n = 5,939), and expressed as difference in the ECG parameter (with 95% confidence interval) per standard deviation of adiposity measure.
Crude: Associations with waist circumference or VAT are adjusted for TBF. Adjusted: Adjusted for age, gender, ethnicity, smoking, alcohol intake, education
level, physical activity, presence of chronic obstructive pulmonary disease, and use of digoxin, class I/III blocking medication, β blockers, calcium channel
blockers, and QT-prolonging drugs. Associations with waist circumference or VAT are additionally adjusted for TBF. Standard deviations: BMI 4.4 kg/m2;
TBF 8.7%; SAT 96.6 cm2; Waist circ 13.2 cm; VAT 55.2 cm2. BMI = body mass index; SAT = subcutaneous adipose tissue; TBF = total body fat; VAT = vis-
ceral adipose tissue; Waist Circ = waist circumference.
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milliseconds; 0.4, 2.1) and total body fat (1.5 milliseconds;
0.2, 2.8) were positively associated with PR interval, whereas
no associations were found for subcutaneous adipose tissue
and waist circumference, and the association of VAT was, if
anything, in the opposite direction (−2.9 milliseconds; −5.0,
−0.9). All measures of adiposity were associated with longer
corrected QT interval, except for subcutaneous adipose tissue
(0.6 millisecond; −0.7, 1.9). All measures of overall adipos-
ity were associated with P-wave axis, T-wave axis, and QRS
axis. Furthermore, waist circumference was negatively as-
sociated with QRS axis (−6.2°; −8.4, −4.0), but not with
P-wave axis (−1.3°; −3.3, 0.6) or T-wave axis (−0.3°; −2.1,
1.5). VAT was negatively associated with P-wave axis (−3.4°;
−5.7, −1.1) and QRS axis (−6.0°; −8.5, −3.4), but not with
T-wave axis (−1.3°; −3.3, 0.7). Including participants with pre-
existing CVD in the analyses did not materially change the
results.
In Figure 2, associations between measures of overall and
abdominal adiposity with ECG parameters are shown in men
and women in adjusted models. In summary, no major or con-
sistent differences were found between men and women in
the association between overall and abdominal adiposity and
any of the ECG parameters. Measures of both overall and ab-
dominal adiposity were associated with a higher heart rate
in both men and women. In both men and women, BMI, total
body fat, subcutaneous adipose tissue, and waist circumference
Figure 1. (continued)
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were associated with a longer P-wave duration, but VAT ad-
justed for total body fat was not associated with P-wave
duration (per SD VAT in men: β −0.6 millisecond; 95%CI:
−2.2, 1.1 and in women: −0.6 millisecond; −2.4, 1.3). Mea-
sures of both overall and abdominal adiposity showed
associations with a longer QRS duration in men, except for
VAT (−0.3 millisecond; −1.2, 0.5). In women, only BMI (0.5
millisecond; 0.1, 1.0) was associated with longer QRS du-
ration. For PR interval, only in women associations were found
with BMI and total body fat. Associations of total body fat
were stronger in women than in men. In women, 1 SD higher
TBF was associated with a 2.9-millisecond (95% CI 1.3, 4.5)
Figure 2. Associations of standardized obesity measures with electrocardiographic (ECG) parameters in men and women aged 45 to 65 years from the Neth-
erlands Epidemiology of Obesity Study (2,331 with VAT and SAT). Results were based on linear regression analyses weighed toward the BMI distribution of
the general population (n = 5,939), and expressed as difference in the ECG parameter (with 95% confidence interval) per standard deviation of adiposity measure.
Shown results were adjusted for age, gender, ethnicity, smoking, alcohol intake, education level, physical activity, presence of chronic obstructive pulmonary
disease, and use of digoxin, class I/III blocking medication, β blockers, calcium channel blockers, and QT-prolonging drugs. Associations with waist cir-
cumference or VAT are additionally adjusted for TBF. Standard deviations: BMI 4.4 kg/m2; TBF 8.7%; SAT 96.6 cm2; Waist circ 13.2 cm; VAT 55.2 cm2.
BMI = body mass index; SAT = subcutaneous adipose tissue; TBF = total body fat; VAT = visceral adipose tissue; Waist Circ = waist circumference.
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longer PR interval, whereas in men, this was −0.9 millisecond
(−3.0, 1.2; p-value interaction 0.002). All measures of adi-
posity showed an association with longer corrected QT interval
in both men and women, except for subcutaneous adipose
tissue in women (−0.2 millisecond; −1.8, 1.4) and a weak as-
sociation of VAT in men (1.0 millisecond; −1.2, 3.1).
Furthermore, the association of BMI was somewhat stron-
ger in men (3.3 milliseconds; 2.0, 4.6) than in women (1.1
milliseconds; 0.2, 1.9; p-value interaction 0.007). In both men
and women, measures of overall and abdominal adiposity were
associated with a more leftward shifted P-wave axis, T-wave
axis, and QRS axis. Only waist circumference was not as-
sociated with P-wave axis in men (0.5°; −2.65, 3.6), and waist
circumference (2.3°; −0.7, 5.2) and VAT (−0.3°; −2.6, 2.1)
were not associated with T-wave axis in men.
As shown in Supplementary Figure 1, for the other sub-
groups, results were similar. We observed differences in
strengths of association of some measures of overall and ab-
dominal adiposity with ECG parameters between subgroups.
However, these differences were inconsistent.
Discussion
In a large cohort of individuals without overt CVD, we
investigated the associations between measures of overall
adiposity, BMI, total body fat, and subcutaneous adipose tissue,
Figure 2. (continued)
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as well as measures of abdominal adiposity, waist circum-
ference, and VAT, with changes in ECG parameters, indicative
of subclinical CVD. We observed that measures of both overall
and abdominal adiposity were associated with ECG mea-
sures associated with subclinical CVD, and that measures of
abdominal adiposity were not more strongly associated with
ECG measures than measures of overall adiposity. When in-
vestigating the associations of adiposity measures with ECG
parameters in different subgroups, there were several inter-
actions observed, which were neither consistent with the ECG
parameters nor with the specific subgroups. Therefore, we are
not able to draw any firm conclusions from these subgroup
analyses.
Measures of overall and abdominal adiposity have been
associated with subclinical CVD in previous literature. We
expected abdominal adiposity to be most strongly associ-
ated with ECG parameters since especially VAT is known to
release several cytokines, chemokines, and hormones, which
can influence organ function and lead to increased progres-
sion of atherosclerosis.1–3
In this study, measures of abdominal adiposity were not
more strongly associated with the ECG parameters than mea-
sures of overall adiposity, which could have several
explanations. First, it is important to realize that associa-
tions with VAT are adjusted for total body fat to look
specifically at the VAT and not general adiposity. In this study,
associations of VAT were attenuated by this adjustment. Fur-
thermore, it is important to realize which specific subclinical
cardiovascular abnormalities are reflected by the different ECG
parameters. Higher heart rate reflects, among others, in-
creased sympathetic activity, which has been associated with
CVD and events.10,25 P-wave duration reflects atrial depolar-
ization and is associated with atrial fibrillation.11 QRS duration
reflects ventricular depolarization and prolongation is asso-
ciated with, among others, congestive heart failure, increased
left ventricular mass, and higher cardiovascular mortality.12,26
PR interval reflects atrial conduction, AV nodal conduction,
and conduction in the heart tissue. Inconsistent associations
have been reported with atrial fibrillation and cardiovascu-
lar mortality.13,27 QT interval reflects ventricular depolarization
and repolarization, and prolongation has been associated with
ventricular arrhythmias and adverse prognosis.14 P-wave axis
reflects atrial orientation and conduction and has been asso-
ciated with increased (cardiovascular) mortality risk.15
Abnormalities in T-wave axis reflect ventricular repolariza-
tion abnormalities, which have been associated with increased
risk of coronary heart disease and heart failure.16 Abnormali-
ties of the QRS axis, or electrical heart axis, which reflects
depolarization in the heart, can have several causes. Litera-
ture regarding the prognostic value of an abnormal QRS axis
is inconclusive, and associations with increased cardiovas-
cular risk are rarely observed in individuals without cardiac
disease.17,28 The deleterious effects of VAT might be stron-
ger for cardiac abnormalities with large metabolic influences,
such as atherosclerosis and less on these ECG parameters that
have more to do with cardiac activation or conduction. For
example, whereas for subclinical atherosclerosis, abdomi-
nal adiposity is often described as the most important, for atrial
fibrillation, similar association of waist circumference, waist:hip
ratio, and BMI was shown.29 Furthermore, epicardial adipose
tissue, a specific visceral fat depot, might show stronger
associations with the ECG parameters investigated in this study
because of its anatomic proximity to the myocardium and con-
duction system.30
A strength of our study is the large study population
(n = 5,939 after exclusion of participants with preexisting
CVD), which made it possible to easily assess associations
with sufficient statistical power. Furthermore, the NEO study
has performed deep phenotyping of the participants, which
made control of potential confounding factors possible.
A limitation of our study is its cross-sectional design, which
precludes any causal conclusions. Furthermore, adiposity mea-
sures were only investigated at 1 moment in time, not taking
into account changes in the different adiposity measures in
relation to the development of subclinical CVD. Moreover,
self-reported variables used in this study could have been
subject to information (recall) bias.
In conclusion, in a population aged 45 to 65 years without
preexisting CVD, measures of both overall and abdominal
adiposity were positively associated with subtle differences
in ECG parameters, associated with subclinical CVD.
Adiposity measures have been proposed to aid in distin-
guishing people at low and high cardiovascular risk, and this
study adds evidence in favor of this potential role of both mea-
sures of overall adiposity, as well as abdominal adiposity in
risk stratification. The role of abdominal and overall adipos-
ity might differ between abnormalities with large metabolic
influences and activation or conduction abnormalities. More-
over, more easily determinable measures, such as BMI or waist
circumference, may have greater potential for application in
clinical practice than for example VAT. Future studies should
evaluate the value of the inclusion of adiposity measures in
ECG diagnoses, such as atrial fibrillation or left ventricular
hypertrophy, and the prognostic value of adding adiposity mea-
sures to current risk prediction tools.
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